朱周静,仝红娟,张彦民,刘斌.化学通报,2021,84(9):942-946.
5-取代-2-羟甲基苯酚衍生物的合成及 体外抗肿瘤活性研究
Synthesis and in Vitro Antitumor activity of 5-Substituted-2-(Hydroxymethyl)phenol Derivatives
投稿时间:2021-01-18  修订日期:2021-02-16
DOI:
中文关键词:  5-取代-2-羟甲基苯酚  N-烷基化反应  抗肿瘤活性  合成
英文关键词:5-substituted-2-(hydroxymethyl)phenol  N-alkylation reaction  antimicrobial activity  synthesis
基金项目:陕西省自然科学基金项目(2018JM7046)、陕西国际商贸学院省级科研平台重点项目(2019XT-2-05)、陕西国际商贸学院“中药药效物质研究”创新团队项目(SSY18TD01)和陕西国际商贸学院一流专业建设项目资助
作者单位E-mail
朱周静 陕西国际商贸学院 医药学院 46930121@qq.com 
仝红娟 陕西国际商贸学院 医药学院  
张彦民 陕西省中药绿色制造技术协同创新中心  
刘斌* 陕西国际商贸学院 医药学院 lb125lb@163.com 
摘要点击次数: 691
全文下载次数: 0
中文摘要:
      以2-羟基-4-甲基苯甲酸为原料, 经过丙酮叉保护、NBS溴代制得中间体7-(溴甲基)-2,2-二甲基-4H-苯并[d][1,3]二氧六环-4-酮(4),再分别和两种杂环仲胺发生N-烷基化反应制得化合物5a-b,最后经过四氢铝锂还原得到目标化合物1a-b,其结构经1H NMR、13C NMR和ESI-MS进行表征。同时,考察了N-烷基化反应和还原反应的反应条件,确定了N-烷基化反应的最佳条件为:物料比为n(吡唑): n(化合物4)= 1.2 : 1;K2CO3用量为n(K2CO3): n(化合物4)= 2.0 : 1;50℃反应5 h。最佳还原反应条件为:LiAlH4用量为n(LiAlH4): n(化合物5a)= 1.2 : 1,-75℃反应时间为1.0 h。此外,采用了MTT法测试了所合成的化合物1a-b对HepG2,HeLa,MCF-7,A5494四种肿瘤细胞以及正常宫颈上皮细胞HUCEC的体外抑制活性。结果表明,目标化合物1a-b对HeLa细胞展现出了明显的抑制作用,其IC50分别为18.4和10.6 μmol ? L-1,而对正常的HUCEC没有抑制活性。这些结果有望为进一步开发具有抗肿瘤活性的2-羟甲基苯酚衍生物提供参考。
英文摘要:
      7-(Bromomethyl)-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (4) was synthesized via acetonide protection and bromination reaction by NBS using 2-hydroxy-4-methylbenzoic acid as material, which was reacted with heterocyclic secondary amine to produce compounds 5a-b. Subsequently, 5a-b were reduced by LiAlH4 to obtain target compounds 1a-b. The structure of 1a-b was characterized by 1H NMR, 13C NMR and ESI-MS. Meanwhile, the reaction conditions for N-alkylation and reduction reactions were investigated and the optimum conditions were as follows: the mole ratio of n (pyrazole) : n (compound 4) = 1.2 : 1, the amount of K2CO3 is n (K2CO3) : n (compound 4) = 2.0 : 1, the reaction was at 50℃ for 5 h; the reduction conditions were as follows: the dosage of LiAlH4 is n (LiAlH4) : n (compound 5a) = 1.2 : 1, the reaction was at -78℃ for 1.0 h. The target compounds 1a-b were tested for their in vitro antitumor activity against HepG2,HeLa,MCF-7,A549 by MTT assay. Compounds 1a-b exhibited significant inhibitory effects on HeLa cells with IC50 of 18.4 and 10.6 ?mol ? L-1, respectively; moreover, Compounds 1a-b showed no significant toxicity to normal HUCEC cells. These results may provide the reference for the further development of 2-hydroxymethyl phenol derivatives as antitumor agents.
查看全文  查看/发表评论  下载PDF阅读器
关闭